|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.47 USD | -3.16% |
|
-2.25% | -21.14% |
| Apr. 18 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| Apr. 18 | Sector Update: Health Care | MT |
TG Therapeutics, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 43.97 million compared to USD 0.08 million a year ago. Net loss was USD 14.42 million compared to USD 52.99 million a year ago.
Basic loss per share from continuing operations was USD 0.1 compared to USD 0.39 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.14% | 1.95B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
TG THERAPEUTICS, INC. 
